home / stock / th:cc / th:cc news

TH:CC News and Press, Theratechnologies Inc. From 10/13/23

Stock Information
Company Name: Theratechnologies Inc.
Stock Symbol: TH:CC
Market: TSXC
Website: theratech.com
Menu
TH:CC TH:CC Quote TH:CC Short TH:CC News TH:CC Articles TH:CC Message Board
Get TH:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
TH:CC - Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, 2021. MONTREAL, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Theratechnologies I...
TH:CC - Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

Milestone for Company’s lead peptide-drug conjugate candidate follows FDA acceptance of protocol amendment for Phase 1 study on June 2, 2023 MONTREAL, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: T...

TH:CC - Theratechnologies Receives January 2024 PDUFA Goal Date for Tesamorelin F8 Formulation sBLA

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, 2021. MONTREAL, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc...

TH:CC - Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates

Q3 2023 consolidated revenue of $20.9 million, adjusted EBITDA of $2.2 million sBLA for F8 formulation of tesamorelin submitted to FDA Agreement in principle on key amendments to loan facility with Marathon MONTREAL, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (&...
TH:CC - Expected Canadian Company Earnings on Tuesday, September 26th, 2023

Solaris Resources Inc. (SLS:CA) is expected to report for Q2 2023 CGX Energy Inc. (OYL:CA) is expected to report for Q1 2024 Edgewater Exploration Ltd. (EDW.H:CA) is expected to report for Q2 2023 CVR Medical Corp (CVM.H:CA) is expected to report for quarter end 2023-06-30 Tower R...

TH:CC - Expected earnings - Theratechnologies Inc.

Theratechnologies Inc. (TH:CA) is expected to report for Q3 2023

TH:CC - Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility

- Removal of Minimum Liquidity Covenant of US$30 Million if F8 Formulation of Tesamorelin is Not Approved by the FDA by March 31, 2024 - Minimum Liquidity Covenant to Decrease Over Time to a Minimum of US$15 million from US$20 Million Based on Attainment of Targeted Adjusted EBITDA ...
TH:CC - Theratechnologies Submits Tesamorelin F8 Formulation sBLA for FDA Review

F8 formulation intended to replace EGRIFTA SV ® with simplified dosing for the treatment of excess abdominal fat in adults with HIV and lipodystrophy MONTREAL, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Co...

TH:CC - Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023

MONTREAL, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Mr. Paul L&#x...

TH:CC - Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update

MONTREAL, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will r...
Previous 10 Next 10